[go: up one dir, main page]

PE20051166A1 - Suplementos nutricionales multivitaminicos y minerales - Google Patents

Suplementos nutricionales multivitaminicos y minerales

Info

Publication number
PE20051166A1
PE20051166A1 PE2005000350A PE2005000350A PE20051166A1 PE 20051166 A1 PE20051166 A1 PE 20051166A1 PE 2005000350 A PE2005000350 A PE 2005000350A PE 2005000350 A PE2005000350 A PE 2005000350A PE 20051166 A1 PE20051166 A1 PE 20051166A1
Authority
PE
Peru
Prior art keywords
compressed
multivitamin
nutritional supplements
mineral nutritional
mineral
Prior art date
Application number
PE2005000350A
Other languages
English (en)
Inventor
William Bubnis
Richard Cotter
Judith Moreines
Bruce W Sutton
Denise L Walters
Neil Wittenberg
Michael G Williams
Jeffrey V Vernon
Scott W Poxon
Paul W Herman
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35064300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20051166(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20051166A1 publication Critical patent/PE20051166A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

REFERIDA A UN SUPLEMENTO NUTRICIONAL QUE COMPRENDE (A) UNA VITAMINA TAL COMO A, C, B6, FOLATO, ENTRE OTRAS; O UN MINERAL TAL COMO SELENIO, CROMO, ZINC, ENTRE OTROS. Y (B) UN AGENTE REDUCTOR DEL COLESTEROL TAL COMO FITOSTEROLES, FITOSTANOLES, ESTATINAS, ENTRE OTROS. DICHO SUPLEMENTO AUMENTA O DISMINUYE LOS NIVELES DE HOMOCISTEINA, O REDUCE LA OXIDACION DEL COLESTEROL DE LIPOPROTEINAS DE BAJA DENSIDAD Y SE ENCUENTRA BAJO LA FORMA DE COMPRIMIDO, COMPRIMIDO RECUBIERTO DE GELATINA, CAPSULA, UNIDAD DE DOSIFICACION MASTICABLE O UN SACHE
PE2005000350A 2004-03-29 2005-03-28 Suplementos nutricionales multivitaminicos y minerales PE20051166A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55724704P 2004-03-29 2004-03-29

Publications (1)

Publication Number Publication Date
PE20051166A1 true PE20051166A1 (es) 2006-02-13

Family

ID=35064300

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000350A PE20051166A1 (es) 2004-03-29 2005-03-28 Suplementos nutricionales multivitaminicos y minerales

Country Status (21)

Country Link
US (3) US20050214383A1 (es)
EP (1) EP1732605B1 (es)
KR (2) KR101389061B1 (es)
CN (1) CN1956734B (es)
AR (1) AR048450A1 (es)
AU (1) AU2005228421B8 (es)
BR (1) BRPI0509374A (es)
CA (2) CA2560595C (es)
DK (1) DK1732605T3 (es)
DO (1) DOP2005000047A (es)
ES (1) ES2733455T3 (es)
HU (1) HUE044810T2 (es)
MY (1) MY151326A (es)
PE (1) PE20051166A1 (es)
PL (1) PL1732605T3 (es)
PT (1) PT1732605T (es)
RU (1) RU2375079C2 (es)
TR (1) TR201909238T4 (es)
TW (1) TWI457079B (es)
WO (1) WO2005094333A2 (es)
ZA (1) ZA200608092B (es)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2733455T3 (es) * 2004-03-29 2019-11-29 Pf Consumer Healthcare 1 Llc Suplementos nutricionales multivitamínicos y minerales
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
US7666448B2 (en) * 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US20060292217A1 (en) * 2005-06-03 2006-12-28 Schmidt Robbin D Nutritional supplement and soft gelatin capsule delivery system
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
WO2007120496A1 (en) * 2006-04-05 2007-10-25 Wyeth Nutritional formulation
US7879375B1 (en) * 2006-06-23 2011-02-01 Arizona Pharmaceuticals, LLC Pharmaceutical composition
JP2010510310A (ja) 2006-11-22 2010-04-02 スタンダード バイオロジックス インコーポレイテッド コウジカビプロテアーゼを使用する処置の方法
KR20100015526A (ko) * 2007-03-12 2010-02-12 피펙스 파마슈티컬스, 인코포레이티드 유리 구리 흡수 및 유리 구리 수준을 안전하게 낮추는데 유용한 경구용 아연 의약
US7794758B2 (en) * 2007-04-05 2010-09-14 Pmc Formulas, Inc. Compounds and methods for promoting cellular health and treatment of cancer
US8394425B2 (en) * 2007-04-05 2013-03-12 Pmc Formulas, Inc. Methods for promoting cellular health and treatment of cancer
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
EP2220208A4 (en) * 2007-11-23 2010-12-29 Rappaport Family Inst For Res USE OF HAPTOGLOBIN ENTYPIZATION FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
AU2008339158B2 (en) * 2007-12-17 2015-01-22 Newtricious B.V. Method of producing egg yolk based functional food product and products obtainable thereby
US20090163452A1 (en) * 2007-12-20 2009-06-25 Schwartz Janice B Compositions and methods for lowering serum cholesterol
WO2009100271A1 (en) * 2008-02-07 2009-08-13 Ralph Brown Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult
WO2010056318A2 (en) * 2008-11-12 2010-05-20 Andrew Loblaw Nutritional supplement
PL2389077T3 (pl) * 2009-01-23 2015-11-30 Wyeth Llc Suplementy diety dla ludzi 50+ do polepszania witalności, odporności, zdrowia oczu i kości
CN105815770A (zh) * 2009-01-23 2016-08-03 惠氏有限责任公司 不具有大剂量的营养补充剂的副作用的多种维生素/矿物质制剂
US8247000B2 (en) 2009-04-10 2012-08-21 Cypress Pharmaceutical, Inc. Phosphate-binding magnesium salts and uses thereof
WO2010141191A1 (en) * 2009-05-13 2010-12-09 Wyeth Llc Method to stabilize a dietary supplement comprising glucosamine
US8911770B2 (en) * 2009-06-18 2014-12-16 Alessandra Grassi Dissolvable dietary supplement strip and methods for using the same
US20110135753A1 (en) * 2009-12-04 2011-06-09 John Wigneswaran Nutritional Supplement For Patients With Chronic Heart Failure
US20110142766A1 (en) * 2009-12-16 2011-06-16 Sal Rafanelli Effervescent Multi-Vitamin Formulation and Methods of Use Thereof
EP2521453B1 (en) * 2010-01-08 2016-05-11 Beth Israel Deaconess Medical Center Combinations of vitamin d and a statin for the treatment of migraine headaches
CN101785854B (zh) * 2010-02-11 2012-10-31 石家庄惠仕医药保健品有限公司 叶黄素多维营养保健药物组合物、其制备方法及应用
RU2456811C2 (ru) * 2010-03-12 2012-07-27 Алексей Юрьевич Колесник Премикс к корму для сельскохозяйственных животных
RU2423108C1 (ru) * 2010-04-12 2011-07-10 Михаил Иванович Лазарев Оптимизированный витаминно-минеральный комплекс
GB201014340D0 (en) * 2010-08-27 2010-10-13 Piraee Mahmood Nutritional supplement formulation comprising saffron and resveratrol
CN101982115A (zh) * 2010-10-14 2011-03-02 张丽娜 一种防治糖尿病慢性糖中毒的组合物
WO2012078597A1 (en) * 2010-12-07 2012-06-14 Freeman Steven R Vegetable based tobacco alternatives and articles comprising same
FR2972330B1 (fr) * 2011-03-08 2015-01-16 Lab Attitude Composition nutraceutique pour limiter l'absorption de lipides alimentaires et pour induire une perte de poids comprenant comme agent actif au moins un extrait de carotte.
US8343517B1 (en) 2011-03-08 2013-01-01 Bezzek Mark S Multivitamin-mineral longevity regimen
US8846061B1 (en) 2011-03-08 2014-09-30 Mark S. Bezzek Multivitamin-mineral regimens for longevity and wellness
US8460718B2 (en) * 2011-04-07 2013-06-11 Lycored Ltd. Synergistic compositions and methods
SI2704734T1 (sl) * 2011-05-03 2015-08-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Sestavek, uporaben za zdravljenje motenj lipidnega metabolizma
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
GB201121519D0 (en) * 2011-12-14 2012-01-25 Ip Science Ltd Fat-based food products
EA025844B1 (ru) * 2012-05-08 2017-02-28 Общество С Ограниченной Ответственностью "Лигур-М" Средство для коррекции гиперхолестеринемии
CN102919856A (zh) * 2012-10-31 2013-02-13 郑州凯利药业有限公司 一种营养素补充剂
US9394318B2 (en) 2012-11-30 2016-07-19 Cypress Pharmaceuticals, Inc. Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
WO2014145072A1 (en) * 2013-03-15 2014-09-18 Everett Laboratories, Inc. Gummy compositions for nutritional supplementation
GB2512314A (en) * 2013-03-26 2014-10-01 Kartar Singh Lalvani Statin composition
AU2014201820B2 (en) 2013-03-27 2016-05-19 Psm Healthcare Limited Stabilized vitamin D formulations
ITRM20130237A1 (it) * 2013-04-19 2013-07-19 Pelliccia Francesco Formulazione per somministrazione orale di una combinazione di integratori alimentari utile per favorire corretti livelli di colesterolo
US20160053281A1 (en) * 2013-08-15 2016-02-25 The University Court Of The University Of Edinburgh Enhanced Expression Of RNA Vectors
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
CA2937107C (en) 2014-01-17 2020-12-22 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
EP2915431A1 (en) * 2014-03-04 2015-09-09 Lifewave, Inc. A nutritional product composition for the mind
EP2915434A1 (en) * 2014-03-04 2015-09-09 Lifewave, Inc. A nutritional product composition for increasing human growth hormone and nitric oxide production
EP2915433A1 (en) * 2014-03-04 2015-09-09 Lifewave, Inc. A nutritional product composition for energy
WO2016081365A1 (en) * 2014-11-19 2016-05-26 Rush University Medical Center Compositions and methods for treating lysosomal disorders
CH710567A1 (de) * 2014-12-30 2016-06-30 Häcki Simone Haarwuchspräparat bzw. Nahrungsergänzungsmittel.
WO2016134406A1 (en) * 2015-02-26 2016-09-01 Dakota Star Capital, Llc Mineral enriched natural supplements
MY191729A (en) * 2015-10-16 2022-07-13 Novex Science Pte Ltd Stable composition of vitamin c and zinc tablet
US10617700B1 (en) 2016-02-26 2020-04-14 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US10039765B1 (en) 2016-02-26 2018-08-07 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
WO2017187335A1 (en) * 2016-04-27 2017-11-02 Abergavenny Nv Food supplement and composition comprising choline butyrate salt and/or butyrylcholine
CN107441117A (zh) * 2016-05-30 2017-12-08 上海诺成药业股份有限公司 一种多维元素钙制剂及其制备方法
US11344575B2 (en) 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment
US11357250B2 (en) 2016-08-15 2022-06-14 Summit Innovation Labs LLC Treatment and prevention of diabetes and obesity
WO2018081048A1 (en) 2016-10-24 2018-05-03 Callion Pharma Antioxidant-enriched multivitamin composition and methods of use
CN106723066A (zh) * 2017-01-12 2017-05-31 浙江格蕾斯生物科技有限公司 一种硼硒和多种维生素复合添加剂
ES2695503B2 (es) * 2017-06-30 2020-05-08 Pharmalink S L Formulaciones encapsuladas
BR102019012637A2 (pt) * 2019-06-18 2020-12-29 Farmoquímica S/A composição nutracêutica combinando probióticos, vitaminas e minerais
WO2021108527A1 (en) * 2019-11-25 2021-06-03 Lian xu li Dietary supplement
USD914868S1 (en) * 2020-04-23 2021-03-30 Access Business Group International Llc. Supplement tablet
KR102271734B1 (ko) 2020-10-21 2021-07-01 한국프라임제약주식회사 건식과립공정용 멀티비타민 약제학적 조성물
DE102021117780A1 (de) 2021-07-09 2023-01-12 Aixbio Gmbh Biomimetisches Nahrungsergänzungsmittel
DE202022106411U1 (de) 2022-11-15 2022-11-21 Aixbio Gmbh Biomimetisches Nahrungsergänzungsmittel

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
US4021582A (en) * 1976-02-13 1977-05-03 Societe D'assistance Technique Pour Produits Nestle S.A. Water-dispersible composition and process for production
US4588717A (en) * 1984-06-13 1986-05-13 David C. Mitchell Medical Research Institute Compounds and vitamin supplements and methods for making same
US6544973B1 (en) * 1995-07-28 2003-04-08 Raisio Benecol Ltd. Substance for lowering high cholesterol level in serum and methods for preparing and using the same
FR2693876A1 (fr) * 1992-07-24 1994-01-28 Vani Complément nutritif à base de micronutriments.
CH685283A5 (it) * 1993-09-21 1995-05-31 Inpharma Sa Composizioni dietetiche ipocolesterolemizzanti.
US6488956B1 (en) * 1994-06-20 2002-12-03 Drugtech Corporation Multi-vitamin and mineral supplements for women
US5869084A (en) * 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
US6139832A (en) 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
ES2238695T3 (es) * 1995-08-14 2005-09-01 Optigenex, Inc. Composiciones de carotenoide-nicotinamida-zinc y metodos de tratamiento usando las mismas.
US6197862B1 (en) * 1995-09-18 2001-03-06 Daikin Industries, Ltd. Filled polytetrafluoroethylene granular powder and process for the production thereof
US6673831B1 (en) * 1996-04-17 2004-01-06 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
JP2000508659A (ja) * 1996-04-17 2000-07-11 メルク エンド カンパニー インコーポレーテッド 心血管疾患関連の危険性を低減する組み合わせ療法
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
US5932561A (en) * 1997-10-24 1999-08-03 Rexall Sundown, Inc. Dietary composition with lipid binding properties for weight management and serum lipid reduction
PT1037607E (pt) * 1997-12-08 2004-07-30 Altana Pharma Ag Nova forma de supositorio compreendendo um composto activo instavel em acido
US5952393A (en) * 1998-02-12 1999-09-14 Sorkin, Jr.; Harlan Lee Composition for reducing serum cholesterol levels
US6110502A (en) * 1998-02-19 2000-08-29 Mcneil-Ppc, Inc. Method for producing water dispersible sterol formulations
FI111513B (fi) * 1998-05-06 2003-08-15 Raisio Benecol Oy Uudet fytosteroli- ja fytostanolirasvahappoesterikoostumukset, niitä sisältävät tuotteet sekä menetelmät niiden valmistamiseksi
US6087353A (en) * 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
US6376481B2 (en) * 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
ZA994696B (en) * 1998-09-09 2000-01-31 Pharmachoice Healthcare Pty Lt Nutritional healthcare formulation.
WO2000015201A2 (en) 1998-09-10 2000-03-23 Forbes Medi-Tech Inc. Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other disorders
US6274170B1 (en) * 1999-02-18 2001-08-14 Richard Heibel Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
US6914073B2 (en) * 1999-03-18 2005-07-05 Bristol Myers Squibb Company Vitamin formulation for cardiovascular health
NZ516349A (en) * 1999-06-23 2004-03-26 Forbes Medi Tech Inc Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
ATE304799T1 (de) * 1999-06-25 2005-10-15 Cognis Ip Man Gmbh Verwendung von nanoskaligen sterolen und sterolestern
US6197832B1 (en) * 1999-09-14 2001-03-06 Harlan Lee Sorkin, Jr. Composition for reducing serum cholesterol levels
JP4381543B2 (ja) * 2000-02-17 2009-12-09 株式会社ファンケル 食品組成物及びその製造方法
US6299896B1 (en) * 2000-04-13 2001-10-09 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
CN1436047A (zh) * 2000-04-14 2003-08-13 马尔斯公司 促进血管健康的组合物和方法
US7147859B2 (en) * 2000-05-15 2006-12-12 Laboratorios Biosintetica Ltda. Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
BR0001794A (pt) * 2000-05-15 2001-12-26 Laboratorios Biosintetica Ltda Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
US20030165572A1 (en) * 2000-09-01 2003-09-04 Nicolas Auriou Water-dispersible encapsulated sterols
US6576285B1 (en) * 2000-11-14 2003-06-10 Sunpure Ltd. Cholesterol lowering beverage
US20020103139A1 (en) * 2000-12-01 2002-08-01 M. Weisspapir Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control
US6933291B2 (en) * 2000-12-01 2005-08-23 N.V. Nutricia Cholesterol lowering supplement
US20030096018A1 (en) * 2000-12-15 2003-05-22 Schloss Caroline Maxine Multi-vitamin and hormone replacement supplement
ATE331512T1 (de) * 2001-01-26 2006-07-15 Schering Corp Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
ATE367810T1 (de) * 2001-03-15 2007-08-15 Dsm Ip Assets Bv Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren
US7090862B2 (en) * 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6787151B2 (en) * 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
PT1443912E (pt) * 2001-10-12 2007-11-28 Elan Pharma Int Ltd Composições tendo uma combinação de características de libertação imediata e de libertação controlada
US20040018248A1 (en) * 2001-11-29 2004-01-29 Adrianne Bendich Composition containing statins and calcium for improved cardiovascular health
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
US20040005358A1 (en) * 2002-04-23 2004-01-08 Slugg Peter H. Modified-release vasopeptidase inhibitor formulation, combinations and method
EP1511468A1 (en) 2002-06-10 2005-03-09 Elan Pharma International Limited Nanoparticulate sterol formulations and sterol combinations
AU2003245313A1 (en) 2002-06-10 2003-12-22 Elan Pharma International, Ltd Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives (statins), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
US6953588B2 (en) * 2002-10-25 2005-10-11 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
RU2237487C2 (ru) * 2002-12-19 2004-10-10 Общество с ограниченной ответственностью "ЛЕОВИТ нутрио" Препарат "кандифит"
DE20316876U1 (de) 2003-11-03 2004-02-05 China Vital Med E.K. Nahrungsergänzungsmittel
US8968768B2 (en) * 2004-03-29 2015-03-03 Wyeth Llc Phytosterol nutritional supplements
ES2733455T3 (es) * 2004-03-29 2019-11-29 Pf Consumer Healthcare 1 Llc Suplementos nutricionales multivitamínicos y minerales
CA2602643C (en) * 2006-10-27 2008-12-23 Iomedix Development International Srl Composition for improving blood cholesterol levels
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
US20080254119A1 (en) * 2007-04-16 2008-10-16 Wyeth Imbedded liquid lubricants for tableting
WO2008156868A2 (en) * 2007-06-20 2008-12-24 Baum Seth J Compositions and methods of treating chronic kidney disease

Also Published As

Publication number Publication date
US20110223250A1 (en) 2011-09-15
PT1732605T (pt) 2019-07-12
US20050214383A1 (en) 2005-09-29
KR20120136418A (ko) 2012-12-18
RU2375079C2 (ru) 2009-12-10
US20140017312A1 (en) 2014-01-16
WO2005094333A3 (en) 2006-02-16
TW200538054A (en) 2005-12-01
AU2005228421B2 (en) 2011-07-21
CA2560595A1 (en) 2005-10-13
ES2733455T3 (es) 2019-11-29
MY151326A (en) 2014-05-15
CA2794424A1 (en) 2005-10-13
CA2560595C (en) 2013-01-22
ZA200608092B (en) 2008-04-30
EP1732605B1 (en) 2019-05-08
TR201909238T4 (tr) 2019-07-22
KR101389061B1 (ko) 2014-04-28
EP1732605A4 (en) 2009-05-27
EP1732605A2 (en) 2006-12-20
AR048450A1 (es) 2006-04-26
DK1732605T3 (da) 2019-06-11
HUE044810T2 (hu) 2019-11-28
US8927012B2 (en) 2015-01-06
DOP2005000047A (es) 2005-11-15
CN1956734B (zh) 2012-10-10
WO2005094333A2 (en) 2005-10-13
AU2005228421B8 (en) 2011-11-17
WO2005094333A8 (en) 2006-01-05
KR101573316B1 (ko) 2015-12-01
CA2794424C (en) 2019-06-04
TWI457079B (zh) 2014-10-21
AU2005228421A1 (en) 2005-10-13
CN1956734A (zh) 2007-05-02
KR20060135042A (ko) 2006-12-28
BRPI0509374A (pt) 2007-09-11
PL1732605T3 (pl) 2019-09-30
RU2006138056A (ru) 2008-05-10

Similar Documents

Publication Publication Date Title
PE20051166A1 (es) Suplementos nutricionales multivitaminicos y minerales
ECSP099575A (es) Estabilidad mejorada en suplementos de vitaminas y minerales
MX2010004113A (es) Composicion para regular el metabolismo de lipidos.
PE20081580A1 (es) Composicion suplementaria nutricional para el tratamiento enfermedades oculares
MX2011012741A (es) Un suplemento que comprende grosellas negras o moras grandes.
ES2631988T1 (es) Composición farmacéutica compuesta por mioinositol y D-chiro-inositol
AR084760A1 (es) Proceso para aislar una composicion proteica y una composicion de grasa desde recortes carneos
PE20060764A1 (es) Composiciones farmaceuticas para el tratamiento y/o prevencion de enfermedades cardiovasculares
PE20081044A1 (es) Composicion oral sin sabor metalico a base de sales de hierro y cobre
AR098653A1 (es) Composición útil para promover la fertilidad femenina, composición de combinación
CL2004001550A1 (es) Formula para infantes o para etapa siguiente del crecimiento, que comprende proteinas, lipidos, carbohidratos y un probiotico, en donde la fuente de lipidos incluye al menos un lc-pufa, y sus usos.
CO6400175A2 (es) Complementos nutricionales para individuos de 50 años de edad o más para mejorar la vitalidad, inmunidad, y salud ocular y ósea
AR053803A1 (es) Uso de acido pinolenico
CL2023001016A1 (es) Biofactores para el tratamiento y la profilaxis de demencia
PE20080286A1 (es) Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca
CL2025001368A1 (es) Composición nutricional para mejorar el desarrollo socioemocional
WO2003068231A3 (de) Mittel, enthaltend folsäure, vitamin b6 und vitamin b12, und dessen verwendung
MX2021014352A (es) Composiciones de fibra soluble de superoxido dismutasa.
PE20040963A1 (es) Suplemento multi-vitaminico y mineral para mujeres embarazadas
CO6410288A2 (es) Una formulación multivitamínica / mineral para combatir los efectos del estrés ambiental; mejorar la inmunidad y mejorar la energía y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega d
AR059577A1 (es) Agente de aceleracion de absorcion del calcio
CO6450623A2 (es) Parasiticidas sanguineos
AR098652A1 (es) Composiciones blanqueadoras para cuidado oral que contienen anfifilos grasos
CL2009001956A1 (es) Composicion nutracéutica que comprende extracto de shilajit (250-500 mg), acido folico (200-500 ug), vitamina b6(20-40 ug), vitamina b12 (4-8 ug) y excipientes aceptables; metodo de fabricacion; y su uso para prevenir o tratar la enfermedad de alzheimer.
RU2012139545A (ru) Биологически активная добавка к пище

Legal Events

Date Code Title Description
FC Refusal